Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TLV/BWAY stock hub

TLV/BWAY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/BWAYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Tel Aviv Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TLV/BWAY

In the news

Latest news · TLV/BWAY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E56.5

P25 n/aP50 n/aP75 n/a

Trailing P/E86.6

P25 n/aP50 n/aP75 n/a

ROE11.2

P25 n/aP50 n/aP75 n/a

ROIC45.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/BWAY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	129
Employees Change	9%
Employees Change Percent	7.5
Enterprise value	ILA 1.8B
Exchange	Tel Aviv Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Devices
Isin	IL0011007189
Last refreshed	2026-05-10
Market cap	ILA 2B
Price	ILA 5,030
Price currency	ILA
Rev Per Employee	1,290,645.74x
Sector	Healthcare
Sic	3845
Symbol	tlv/BWAY
Website	https://www.brainsway.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.2%
EV Earnings	75.36x
EV/EBIT	132.04x
EV/EBITDA	97.39x
EV/FCF	37.68x
EV/Sales	10.93x
FCF yield	2.4%
Forward P/E	56.5x
P/B ratio	8.63x
P/E ratio	86.59x
P/S ratio	12.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.28%
EBITDA Margin	9.8%
FCF margin	29.01%
Gross margin	75.42%
Gross Profit	ILA 125.6M
Gross Profit Growth	28.79%
Gross Profit Growth Q	30.63%
Gross Profit Growth3 Y	25.24%
Gross Profit Growth5 Y	18.3%
Net Income	ILA 24.1M
Net Income Growth	159.33%
Net Income Growth Q	85.72%
Net Income Growth Quarters	11%
Net Income Growth Years	3%
Pretax Margin	14.76%
Profit Margin	14.5%
Profit Per Employee	ILA 187,202
Profitable Years	2
ROA	2.6
Roa5y	-3.63
ROCE	4.77
ROE	11.18
Roe5y	-7.13
ROIC	45.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.27%
Cagr15y	3.03%
Cagr1y	220.43%
Cagr3y	159.46%
Cagr5y	29.77%
EPS Growth	229.1
EPS Growth Q	321.2
EPS Growth Quarters	11
EPS Growth Years	3
FCF Growth	132.9%
OCF Growth	69.82%
Revenue Growth	27.33x
Revenue Growth Q	27.43x
Revenue Growth Quarters	10x
Revenue Growth Years	3x
Revenue Growth3 Y	24.33x
Revenue Growth5 Y	18.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ILA 0.5
Assets	ILA 360.9M
Cash	ILA 215.8M
Current Assets	ILA 243.2M
Current Liabilities	ILA 65.3M
Debt	ILA 21.7M
Debt EBITDA	ILA 1.16
Debt Equity	ILA 0.09
Debt FCF	ILA 0.45
Equity	ILA 233.2M
Interest Coverage	2.77
Liabilities	ILA 127.6M
Long Term Assets	ILA 117.7M
Long Term Liabilities	ILA 62.4M
Net Cash	ILA 194.1M
Net Cash By Market Cap	ILA 9.64
Net Cash Growth	-4.45%
Net Debt EBITDA	ILA -11.9
Net Debt Equity	ILA -0.83
Net Debt FCF	ILA -4.02
Tangible Book Value	ILA 233.2M
Tangible Book Value Per Share	ILA 5.96
WACC	5.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.73
Inventory Turnover	2.35
Net Working Capital	ILA -16.9M
Quick ratio	3.23
Working Capital	ILA 195.5M
Working Capital Turnover	ILA 2.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	190.75%
1Y total return	220.18%
200-day SMA	3,173.2
3Y total return	1,647.74%
50-day SMA	4,346.8
50-day SMA vs 200-day SMA	50over200
5Y total return	267.96%
All Time High	7,440
All Time High Change	-32.39%
All Time High Date	2013-02-10
All Time Low	272
All Time Low Change	1,749.26%
All Time Low Date	2023-05-03
ATR	195.8
Beta	0.22
Beta1y	0.55
Beta2y	0.66
Ch YTD	60.96
High	5,037
High52	5,123
High52 Date	2026-05-04
High52ch	-1.82%
Low	4,839
Low52	1,498
Low52 Date	2025-05-12
Low52ch	235.78%
Ma50ch	15.72%
Price vs 200-day SMA	58.52%
RSI	64.5
RSI Monthly	88.65
RSI Weekly	74.39
Sharpe ratio	2.87x
Sortino ratio	5.47
Total Return	-13.91%
Tr YTD	60.96
Tr15y	56.5%
Tr1m	17.55%
Tr1w	1.05%
Tr3m	51.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA 13.8M
Operating Income Growth	210.8
Operating Income Growth Q	344.5
Operating margin	8.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,875,255%
Net Borrowing	-2,413,632
Shares Insiders	17.08%
Shares Institutions	22.32%
Shares Out	40,037,529
Shares Qo Q	7.02%
Shares Yo Y	13.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA 44.5M
Average Volume	97,550.5x
Bv Per Share	5.96
CAPEX	ILA -7.5M
Ch10y	190.8
Ch15y	56.5
Ch1m	17.55
Ch1w	1.05
Ch1y	220.2
Ch3m	51.1
Ch3y	1,647.7
Ch5y	268
Ch6m	93.54
Change	0.8%
Change From Open	0.8
Close	4,990
Days Gap	0
Depreciation Amortization	2,300,493
Dollar Volume	403,632,350
Earnings Date	2026-05-13
EBIT	ILA 13.8M
EBITDA	ILA 16.3M
EPS	ILA 0.58
F Score	5
FCF	ILA 48.3M
FCF EV Yield	2.65x
FCF Per Share	ILA 1.21
Financing CF	-5,448,292
Fiscal Year End	December
Founded	2,003
Graham Number	889.15889
Graham Upside	-82.32
Income Tax	ILA 430,380
Investing CF	-55,681,608
Is Primary Listing	1
Last Earnings Date	2026-03-11
Last Report Date	2025-12-31
Last Split Date	2011-05-22
Last Split Type	Reverse
Ma150	3,461.2
Ma150ch	45.33%
Ma20	4,760.5
Ma20ch	5.66%
Net CF	-5,244,260
Next Earnings Date	2026-05-13
Open	4,990
P FCF Ratio	41.7
P OCF Ratio	36.12
Position In Range	96.46
Ppne	37,074,780
Price Date	2026-05-08
Price EBITDA	ILA 123
Ptbv Ratio	8.63
Relative Volume	0.85x
Revenue	166,493,300x
SBC By Revenue	2.29x
Share Based Comp	3,812,848
Tax By Revenue	0.26x
Tax Rate	1.75%
Tr6m	93.54%
Volume	80,245
Z Score	3.73

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/BWAY pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/BWAY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/BWAY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.3%

Share of float held by funds and institutions

Insider ownership

+17.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.9%

Negative means the company is buying back shares.

Technical

TLV/BWAY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.5

Neutral momentum band

Price vs 200-day MA

+58.5%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

2.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/BWAY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/BWAY stock rating?

tlv/BWAY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/BWAY analysis?

The full report lives at /stocks/tlv/BWAY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/BWAY?

The latest report frames tlv/BWAY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/BWAY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.